Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05670288 · ClinicalTrials.gov registry record

Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury

A clinical trial of Spinal Cord Injuries and Gut Microbiome, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
35
Enrollment target
1
Study location

NCT05670288 is a study of Spinal Cord Injuries and Gut Microbiome that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 35 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05670288, a study of Spinal Cord Injuries and Gut Microbiome, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

The Investigators will recruit 35 participants with acute SCI (within 6 weeks of injury) Fasting blood collection and bowel function survey will be conducted 3 times: at baseline \[within 6 weeks of injury\], 6, and 12 months after SCI. Stool will be collected for gut microbiome analysis 3 times.

Study Locations (1)

Alabama

  • The University of Alabama at Birmingahm - Birmingham

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2023-10-15
Est. Completion 2027-02-28

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05670288

The ClinicalTrials.gov registry entry for NCT05670288 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (43% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 0 interventions.

NCT05670288 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05670288 about?

NCT05670288 is a clinical study titled "Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury". The Investigators will recruit 35 participants with acute SCI (within 6 weeks of injury) Fasting blood collection and bowel function survey will be conducted 3 times: at baseline \[within 6 weeks of injury\], 6, and 12 months after SCI. Stool will be collected for gut microbiome analysis 3 times.

What is the current status of trial NCT05670288?

This trial is currently recruiting. The enrollment target is 35 participants. The study started on 2023-10-15. Estimated completion is 2027-02-28.

What conditions does trial NCT05670288 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Gut Microbiome.

Who is sponsoring clinical trial NCT05670288?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05670288 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.